Risk and benefits of continuous subcutaneous insulin infusion (CSII) treatment in school children and adolescents
- 1 August 2006
- journal article
- review article
- Published by Hindawi Limited in Pediatric Diabetes
- Vol. 7 (s4) , 20-24
- https://doi.org/10.1111/j.1399-543x.2006.00167.x
Abstract
Continuous subcutaneous insulin infusion (CSII) therapy with technically advanced modern insulin pumps is a treatment option enabling patients and multidisciplinary diabetes teams to achieve all current goals for the treatment of children and adolescents with type 1 diabetes mellitus (T1DM): near-normoglycemia, low rate of hypoglycemia, preventing or delaying long-term complications and increasing quality of life. Clinical studies demonstrate that CSII therapy reduces glycosylated hemoglobin A1c (HbA1c) with a concomitant decrease in the rate of hypoglycemic events, without excessive weight gain and with an increase of patients' treatment satisfaction in all pediatric age groups. With the development of continuous glucose sensing coupled with an insulin pump, patients can hope for an ever-increasing technological support for the management of insulin therapy in the foreseeable future.Keywords
This publication has 30 references indexed in Scilit:
- Insulin pumpsArchives of Disease in Childhood, 2003
- Safety and Effectiveness of Insulin Pump Therapy in Children and Adolescents With Type 1 DiabetesDiabetes Care, 2003
- Continuous Subcutaneous Insulin Infusion in Children and Adolescents with Diabetes Mellitus: Decreased HbA1c with Low Risk of HypoglycemiaJournal of Pediatric Endocrinology and Metabolism, 2003
- Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groupsPediatric Diabetes, 2002
- Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)The Journal of Pediatrics, 2001
- Continuous Subcutaneous Insulin Infusion Therapy for Children and Adolescents: An Option for Routine Diabetes CarePediatrics, 2001
- Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.Diabetes Care, 1999
- Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications TrialThe Journal of Pediatrics, 1994
- Pharmacokinetics of continuous subcutaneous insulin infusionDiabetologia, 1983
- Reduction to Normal of Plasma Glucose in Juvenile Diabetes by Subcutaneous Administration of Insulin with a Portable Infusion PumpNew England Journal of Medicine, 1979